Price Alert

BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Real-Time Price · USD

3.68

0.13 (3.66%)

At close: Sep 05, 2025, 3:59 PM

3.64

-1.09%

After-hours: Sep 05, 2025, 04:10 PM EDT

BioLineRx Statistics

Share Statistics

BioLineRx has 79.86M shares outstanding. The number of shares has increased by 3562.35% in one year.

Shares Outstanding	79.86M
Shares Change (YoY)	3562.35%
Shares Change (QoQ)	2046.1%
Owned by Institutions (%)	0%
Shares Floating	79.41M
Failed to Deliver (FTD) Shares	943
FTD / Avg. Volume	1.14%

Short Selling Information

The latest short interest is 203.23K, so 5.46% of the outstanding shares have been sold short.

Short Interest	203.23K
Short % of Shares Out	5.46%
Short % of Float	5.47%
Short Ratio (days to cover)	4.66

Valuation Ratios

The PE ratio is -74.15 and the forward PE ratio is -13.65. BioLineRx's PEG ratio is 0.84.

PE Ratio	-74.15
Forward PE	-13.65
PS Ratio	23.63
Forward PS	42.6
PB Ratio	50.79
P/FCF Ratio	-15.56
PEG Ratio	0.84

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioLineRx.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.12.

Current Ratio	1.76
Quick Ratio	1.56
Debt / Equity	1.12
Debt / EBITDA	3.84
Debt / FCF	-0.34
Interest Coverage	-2.25

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$1.03M
Profits Per Employee	$-329.32K
Employee Count	28
Asset Turnover	0.74
Inventory Turnover	2.95

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -85% in the last 52 weeks. The beta is 0.89, so BioLineRx's price volatility has been higher than the market average.

Beta	0.89
52-Week Price Change	-85%
50-Day Moving Average	4.1
200-Day Moving Average	5.04
Relative Strength Index (RSI)	44.89
Average Volume (20 Days)	82,412

Income Statement

In the last 12 months, BioLineRx had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.

Revenue	28.94M
Gross Profit	19.68M
Operating Income	-20.41M
Net Income	-9.22M
EBITDA	3.92M
EBIT	-147K
Earnings Per Share (EPS)	-0.12

Full Income Statement

Balance Sheet

The company has 10.44M in cash and 15.04M in debt, giving a net cash position of -4.6M.

Cash & Cash Equivalents	10.44M
Total Debt	15.04M
Net Cash	-4.6M
Retained Earnings	-399.83M
Total Assets	43.27M
Working Capital	16.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.87M and capital expenditures -54K, giving a free cash flow of -43.93M.

Operating Cash Flow	-43.87M
Capital Expenditures	-54K
Free Cash Flow	-43.93M
FCF Per Share	-0.55

Full Cash Flow Statement

Margins

Gross margin is 67.99%, with operating and profit margins of -70.52% and -31.86%.

Gross Margin	67.99%
Operating Margin	-70.52%
Pretax Margin	-31.86%
Profit Margin	-31.86%
EBITDA Margin	13.54%
EBIT Margin	-70.52%
FCF Margin	-151.79%

Dividends & Yields

BLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for BLRX is $19, which is 416.3% higher than the current price. The consensus rating is "Buy".

Price Target	$19
Price Target Difference	416.3%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jan 30, 2025. It was a backward split with a ratio of 1:40.

Last Split Date	Jan 30, 2025
Split Type	backward
Split Ratio	1:40

Scores

Altman Z-Score	-4.55
Piotroski F-Score	4